Guardant Health (GH) Total Current Liabilities (2017 - 2026)
Guardant Health's (GH) quarterly Total Current Liabilities came in at $292.1 million in Q1 2026, up 29.41% year-on-year from $225.8 million in Q1 2025, and down 3.5% quarter-over-quarter from $302.7 million in Q4 2025.
Guardant Health (GH) Total Current Liabilities (2017 - 2026) Analysis & Trends
Guardant Health has disclosed Total Current Liabilities across 10 years of filings, most recently posting $292.1 million for Q1 2026.
- Total Current Liabilities for Q1 2026 came in at $292.1 million, up 29.41% year-over-year; the trailing twelve-month figure through Mar 2026 was $292.1 million (up 29.41% YoY), and the FY2025 annual result was $302.7 million, up 34.2% from the prior year.
- Total Current Liabilities came in at $292.1 million for Q1 2026 at Guardant Health, down from $302.7 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $302.7 million in Q4 2025 to a low of $167.8 million in Q2 2022.
- The 5-year median for Total Current Liabilities is $220.0 million (2024), against an average of $220.2 million.
- Across the five-year window, Total Current Liabilities surged 139.59% in 2022 and slipped 12.97% in 2024, its largest moves.
- Guardant Health's Total Current Liabilities stood at $193.2 million in 2022, then grew by 6.57% to $205.9 million in 2023, then advanced by 9.55% to $225.6 million in 2024, then surged by 34.2% to $302.7 million in 2025, then retreated by 3.5% to $292.1 million in 2026.
- The last three Total Current Liabilities figures came in at $292.1 million (Q1 2026), $302.7 million (Q4 2025), and $236.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | 2.27 Bn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 14.62 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 7.46 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 1.30 Bn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 2.27 Bn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 8.33 Bn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 558.26 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 1.57 Bn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 1.11 Bn |
| 10 | Guardant Health | 16.38 Bn | 15.28 Bn | 196.75 Mn | 292.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 292.15 Mn |
| Dec 31, 2025 | 302.73 Mn |
| Sep 30, 2025 | 236.92 Mn |
| Jun 30, 2025 | 238.43 Mn |
| Mar 31, 2025 | 225.75 Mn |
| Dec 31, 2024 | 225.58 Mn |
| Sep 30, 2024 | 197.35 Mn |
| Jun 30, 2024 | 201.57 Mn |
| Mar 31, 2024 | 220.01 Mn |
| Dec 31, 2023 | 205.92 Mn |
| Sep 30, 2023 | 226.75 Mn |
| Jun 30, 2023 | 200.93 Mn |
| Mar 31, 2023 | 204.16 Mn |
| Dec 31, 2022 | 193.22 Mn |
| Sep 30, 2022 | 175.12 Mn |
| Jun 30, 2022 | 167.76 Mn |
| Mar 31, 2022 | 228.81 Mn |
| Dec 31, 2021 | 194.69 Mn |
| Sep 30, 2021 | 102.30 Mn |
| Jun 30, 2021 | 96.61 Mn |